CR3‐dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement‐opsonized Cryptococcus neoformans
Open Access
- 1 June 1997
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 91 (2) , 289-296
- https://doi.org/10.1046/j.1365-2567.1997.00238.x
Abstract
Phagocytosis is a fundamental process in innate resistance to infection. We have used the pathogenic yeast Cryptococcus neoformans to study the interaction of this encapsulated organism with murine macrophages in vitro. In the absence of exogenous opsonins the encapsulated yeast is almost totally resistant to ingestion by murine macrophages. Owing to its ability to activate the alternative complement pathway, the anti‐phagocytic properties of the polysaccharide capsule can be partially overcome following opsonization in vitro with non‐immune mouse serum and subsequent phagocytosis via complement receptors. Here, we demonstrate the importance of the complement receptor type 3 (CR3) in in vitro phagocytosis of the yeast and in in vivo resistance to infection. In vitro, 70% of a population of resident murine macrophages are able to ingest C. neoformans and then only inefficiently (1–2 organisms per cell). Previously we have shown that tumour necrosis factor‐α (TNF‐α) and granulocyte–macrophage colony‐stimulating factor (GM‐CSF) efficiently enhance ingestion of serum‐opsonized encapsulated C. neoformans, and we now show that the cytokines convert a population of resident macrophages to a state where all the cells are competent for ingestion of large numbers of yeasts (6–8 per cell). We also show that these cytokines have a direct effect on CR3, as enhanced levels of complement‐opsonized sheep red blood cells (EIgMC) bind to macrophages activated in this way. However, cytokines that have previously been shown to enhance phagocytosis of EIgMC have no effect on ingestion of encapsulated C. neoformans. These results demonstrate that the cytokines regulating CR3‐dependent ingestion of C. neoformans are different to those regulating ingestion of EIgMC and reinforce the importance of studying pathogens rather than inert ligands in understanding the regulation of phagocytosis.Keywords
This publication has 26 references indexed in Scilit:
- Differential requirements for cellular cytoskeleton in human macrophage complement receptor- and Fc receptor-mediated phagocytosis.The Journal of Immunology, 1991
- Cytokine regulation of complement receptor-mediated ingestion by mouse peritoneal macrophages. M-CSF and IL-4 activate phagocytosis by a common mechanism requiring autostimulation by IFN-beta.The Journal of Immunology, 1991
- Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.The Journal of Immunology, 1990
- Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells.The Journal of Experimental Medicine, 1989
- An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors.The Journal of Immunology, 1989
- Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages.Journal of Clinical Investigation, 1988
- TUMOR NECROSIS FACTOR IS THE MAJOR MONOCYTE PRODUCT THAT INCREASES COMPLEMENT RECEPTOR EXPRESSION ON MATURE HUMAN-NEUTROPHILS1988
- Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.The Journal of Experimental Medicine, 1987
- Phorbol esters cause sequential activation and deactivation of complement receptors on polymorphonuclear leukocytes.The Journal of Immunology, 1986
- Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.The Journal of Immunology, 1985